Alcon AG | ALC - Sales Revenues

Stock Price
51.42
Daily Change
1.00 1.98%
Monthly
-17.81%
Yearly
-30.59%
Q2 Forecast
49.42

Alcon AG reported $2.69B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AstraZeneca USD 15.29B 213M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
UCB EUR 4.25B 764M Dec/2025